Assessing the Prognostic Value of Serial Seattle Angina Questionnaire Scores in Chronic Coronary Disease
Evan L. O’Keefe, John Saxon, Y Cho, Philip G. Jones et autres
0 citationsCirculation Population Health and Outcomes
Federica Ramani
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
60Publications signalées
2245Citations signalées
0Affiliations récentes
Domaines associés
Cardiovascular Function and Risk FactorsCardiomyopathy and Myosin StudiesCardiac pacing and defibrillation studiesAcute Myocardial Infarction ResearchCardiac Structural Anomalies and Repair
Publications récentes
Variability in Cardiac Stress Test Interpretation: Agreement Between Enrollment Sites and Core Laboratories in the Global ISCHEMIA Trial
Evan L. O’Keefe, Brett W. Sperry, Philip G. Jones, James H. O’Keefe et autres
0 citationsCirculation Population Health and Outcomes
The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial
Francesco Fioretti, Faı̈ez Zannad, Irina Barash, Stefano Corda et autres
1 citationEuropean Journal of Heart Failure
Cardiovascular outcomes and aortic growth in pregnant women with Turner syndrome: data from the European Society of Cardiology EURObservational Research Programme Registry of Pregnancy and Cardiac Disease (ROPAC) III
Johanna A van der Zande, Jasmin Grewal, Arie Franx, Wael Al Mahmeed et autres
1 citationEuropean Journal of Preventive Cardiology
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA
Chetan Huded, John A. Spertus, Philip G. Jones, Sean M. O’Brien et autres
7 citationsCirculation
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials
Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler, Ciaran J. McMullan et autres
44 citationsThe Lancet
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash et autres
81 citationsThe Lancet
Pregnancy outcomes in women with heritable thoracic aortic disease: data from the EORP ESC registry of pregnancy and cardiac disease (ROPAC) III
Johanna A van der Zande, Julie De Backer, Guillaume Jondeau, Osama Ahmad et autres
11 citationsEuropean Heart Journal - Quality of Care and Clinical Outcomes
Valve replacement during pregnancy: literature review including new data from the Registry Of Pregnancy And Cardiac disease III
Johanna A van der Zande, С. О. Сіромаха, Ghada Youssef, Laura Galián-Gay et autres
2 citationsEuropean Journal of Cardio-Thoracic Surgery
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial
James Slater, David J. Maron, Philip G. Jones, Sripal Bangalore et autres
5 citationsCirculation Cardiovascular Quality and Outcomes
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial
Harmony R. Reynolds, Courtney Page, Leslee J. Shaw, Daniel S. Berman et autres
3 citationsCirculation Cardiovascular Interventions
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial
Radosław Pracoń, John A. Spertus, Samuel Broderick, Sripal Bangalore et autres
2 citationsCirculation Cardiovascular Interventions
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.